Quick Facts

FONT-SIZE

Plus

Neg

SHARE

mail

E-MAIL

Telik Q2 Loss Narrows

RELATED NEWS

Telik Q4 Loss Narrows

Trade TELK now with

8/10/2012 8:29 PM ET

Clinical stage drug development company Telik, Inc. (TELK: Quote) posted second-quarter net loss of $2.1 million or $1.11 per share, narrower than $3.0 million or $1.67 per share in the previous year quarter.

Loss from operations narrowed to $2.06 million from $3.01 million in the comparable quarter last year.

Click here to receive FREE breaking news email alerts for TELIK INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Quick Facts

<<Previous 119 Articles Next>>

Editors Pick

Obama's Approval Rating Holding Steady Despite Scandals

While a recent series of scandals have caused headaches for the White House, the results of a Washington Post-ABC News poll released Tuesday suggest that the news has not had an impact on President Barack Obama's approval rating. The poll showed that 51 percent of Americans approve of the way Obama is handling his job as president compared to 44 percent that disapprove.

Stocks Moving Modestly Higher On Upbeat Earnings News - U.S. Commentary

Stocks have moved modestly higher in early trading on Tuesday, benefiting from a positive reaction to some upbeat earnings news. The major averages have all moved to the upside, offsetting the slim losses posted in the previous session. The major averages are currently posting modest gains, near their highs for the young session.

U.K. Inflation Eases To 7-Month Low

U.K. consumer price inflation slowed more-than-expected to a seven-month low in April on falling petrol and air fares, official data revealed Tuesday. The slowdown provides relief for consumers as it raises purchasing power, while it gives more scope for the central bank to ease monetary policy.

FREE Newsletters & Alerts

Breaking News Alerts

Daily Market Briefing

Health

Technology

Biotechnology

signup

Follow RTT

Most Read
Most E-Mailed

FDA Clears Oramed Pharma's IND For ORMD-0801 - Quick Facts

Pre-market Movers For May 16 (WMT, AAPL, GOOG, KSS, CSCO, TSLA, EGLE)

Plains Exploration Declars Special Dividend - Quick Facts

Richemont Profit Climbs 30% As Sales Increase; Chairman To Take One Year Leave

Genesys To Buy SoundBite Communications For $5.00 Per Share

Pre-market Movers For May 20 (YHOO, WCRX, ACT, WBSN, CHK, PXP, XNPT, PPHM)

3i Group Posts Profit In FY13 - Quick Facts

Novartis Says BOLERO-3 Study On Afinitor Meets Main Goal

Synthomer Remains Cautious About Full-year Outlook On Weaker Demand In Europe

MITIE Group Fiscal Year Pretax Profit Decreases - Quick Facts

FDA Clears Oramed Pharma's IND For ORMD-0801 - Quick Facts

Yahoo! Says Mexico Appeals Court Reverses $2.75 Bln Verdict

GE Capital To Pay $6.5 Bln In Dividends To GE In 2013, Plans Special Dividend

Zytronic H1 Pretax Profit Decreases - Quick Facts

William Lyon Homes Prices IPO At $25/share, Above Estimated Range - Quick Facts

Customers Bancorp Reports Pricing Of Public Offering Of 5.37Mln Shares At $16.75

Reports: Dow Chemical Ordered To Pay $1.2 Billion In Price-fixing Case

Centrum Capital Approves Bonus Issue, Stock Split

Century Enka To Pay 60% Dividend For FY13

United Spirits Q4 Stand-Alone Profit Up More Than Five-Fold

FREE Newsletters, Analysis & Alerts

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.

Email Address